ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-CVS / Coagulation and vascular signalling

Vasopressin

Also known as: Arginine vasopressin · Antidiuretic hormone · Vasostrict

Approved comparator existsEvidence grade A: Approved comparator exists

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

Vasopressin is an endogenous cyclic peptide involved in vascular and water-balance signaling.

Evidence position

The regulated injection record supports Grade A for the named finished product.

What the record does not establish

An active-ingredient match does not transfer formulation, sterility, potency or stability controls.

Sources

  • 01
    Vasostrict prescribing informationDailyMed / U.S. National Library of Medicine
    Shows
    Current U.S. label for a defined vasopressin injection product
    Does not show
    Does not qualify another concentration, route, formulation or source

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBMED / FOUND RECORDS

  1. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.Chest / 2023 NovPMID 37479058 / DOI 10.1016/j.chest.2023.07.009
  2. Vasopressin. / 2006PMID 29999710
  3. The Biology of Vasopressin.Biomedicines / 2021 Jan 18PMID 33477721 / DOI 10.3390/biomedicines9010089
  4. Vasopressin.Seminars in respiratory and critical care medicine / 2004 DecPMID 16088512 / DOI 10.1055/s-2004-860984
  5. Copeptin analysis in endocrine disorders.Frontiers in endocrinology / 2023PMID 37859988 / DOI 10.3389/fendo.2023.1230045

CLINICALTRIALS.GOV / FOUND RECORDS

  1. Inhibition of Aggressive Behavior in Participants With Fragile X SyndromeNOT_YET_RECRUITING / PHASE2 / Azevan PharmaceuticalsNCT07328529 / DIRECT title MATCH: Vasopressin
  2. Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill PatientsUNKNOWN / PHASE4 / University of ThessalyNCT06265259 / DIRECT title MATCH: Vasopressin
  3. Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver TransplantCOMPLETED / NA / Medical University of South CarolinaNCT00886262 / DIRECT intervention MATCH: Vasopressin
  4. Vasopressin Deficiency in Hemorrhagic ShockCOMPLETED / NO PHASE / The University of Texas Health Science Center at San AntonioNCT01107314 / DIRECT title MATCH: Vasopressin
  5. Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive DisorderCOMPLETED / PHASE2 / SanofiNCT01606384 / DIRECT intervention MATCH: Vasopressin

Related compounds